The European Commission has approved Novo Holdings A/S’ acquisition of Catalent, Inc., a global contract development and manufacturing organization headquartered in New Jersey, as well as Novo Nordisk’s subsequent acquisition of three manufacturing sites from Novo Holdings A/S.   The industry has been closely monitoring the situation between Novo Nordisk and Catalent since its announcement earlier this year. Catalent is a leading provider of outsourcing services, offering expertise to numerous...